15 Participants Needed

CI Therapy + Sensory Training for Stroke

MB
Overseen ByMary Bowman, BS OT
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a treatment called Constraint-Induced Movement Therapy (CI Therapy) combined with sensory training for stroke survivors. The goal is to improve the use and quality of movement in the arm and hand most affected by the stroke, while also addressing sensory issues. Participants will undergo an intensive therapy program over 2-3 weeks to determine if adding sensory training enhances recovery without hindering motor skill progress. Ideal participants are those who had a stroke at least six months ago and have moderate to severe movement issues in their affected arm but can still perform basic movements like shoulder, elbow, or wrist motions. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance stroke recovery therapies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this protocol is safe for stroke patients?

Research shows that Constraint-Induced Movement Therapy (CIMT), like the one used in this trial, is generally safe for stroke patients. Studies have found that combining CIMT with other rehabilitation methods improves movement with only minor side effects. Specifically, no major impacts on grip strength, sensation, pain, or overall quality of life occur after the therapy.

Another study found that CIMT helps improve hand function, indicating the therapy is effective and well-tolerated. Importantly, when CIMT was used in different ways, such as with other therapies, improvements occurred without major side effects. This suggests that adding sensory elements, as in this trial, should be safe. However, since the sensory part is new, its specific effects are still being studied.

Overall, past research considers CIMT safe. The addition of sensory training is being explored to see if it offers more benefits without adding new risks.12345

Why are researchers excited about this trial?

Constraint-Induced Movement Therapy Plus Sensory Components (CI Therapy + Sensory Components) is unique because it combines physical rehabilitation with sensory training, which is not typical in standard stroke recovery methods. Standard treatments often focus solely on physical exercises or occupational therapy to regain movement. However, CI Therapy + Sensory Components adds sensory retraining, which helps patients not only move better but also feel and respond more accurately to touch and other stimuli. Researchers are excited because this comprehensive approach could enhance brain plasticity, leading to faster and more effective recovery after a stroke.

What evidence suggests that CI Therapy plus sensory components is effective for stroke recovery?

Research has shown that Constraint-Induced Movement Therapy (CI Therapy) can improve arm and hand function after a stroke. Studies have found that this therapy encourages patients to use their affected arm more in everyday activities, leading to better movement quality. For instance, one study discovered that patients who underwent CI Therapy had much better arm function than those who did not. In this trial, all participants will receive CI Therapy with added sensory components. While traditional CI Therapy mainly focuses on improving movement, adding sensory training aims to address issues with feeling and touch, which have not been studied as much. Early signs suggest that including sensory training might boost overall recovery for stroke patients.15678

Who Is on the Research Team?

DM

David Morris, PhD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults who've had a stroke at least 6 months ago and have mild-to-severe difficulty moving their arm but can still do some basic movements. They should be able to use the affected arm a little in daily life, as shown by specific test scores.

Inclusion Criteria

I can move my shoulder, elbow, wrist, fingers, or thumb a little.
My use of my weaker arm or hand scores less than 2.5 on a specific test.
It has been over 6 months since my stroke.

Exclusion Criteria

I am unable to understand or answer specific health questions or give informed consent.
I cannot go to the lab for treatment.
You have a score less than 24 on a brain function test called the Mini Mental State Exam.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive CI therapy plus somatosensory training components for the more-affected upper extremity for 2-3 weeks, depending on the level of UE impairment severity.

2-3 weeks
5 visits per week (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments including the Motor Activity Log and other measures.

3 months
Follow-up assessments conducted via telephone

What Are the Treatments Tested in This Trial?

Interventions

  • Constraint-Induced Movement Therapy Plus Sensory Components
Trial Overview The study tests Constraint-Induced Movement Therapy with added sensory training on people after a stroke. It involves intensive behavioral techniques, motor training, tasks that encourage using the weaker arm, and strategies to improve its everyday use.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Grade 2-5 CI Therapy + Sensory ComponentsExperimental Treatment1 Intervention

Constraint-Induced Movement Therapy Plus Sensory Components is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Constraint-Induced Movement Therapy for:
🇪🇺
Approved in European Union as Constraint-Induced Movement Therapy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

In a study involving 32 stroke patients, constraint-induced movement therapy (CIT) significantly improved motor function, functional independence, and quality of life compared to a control intervention that also involved hand restraint.
CIT combined intensive training of the affected limb with restraint of the less affected limb, leading to better outcomes in daily activities and overall health-related quality of life after just 3 weeks of treatment.
Constraint-induced therapy versus dose-matched control intervention to improve motor ability, basic/extended daily functions, and quality of life in stroke.Lin, KC., Wu, CY., Liu, JS., et al.[2019]
Constraint-Induced Movement therapy (CI therapy) effectively improves motor function and upper extremity use in individuals with hemiparesis from chronic stroke by addressing learned nonuse and promoting cortical reorganization.
CI therapy may also benefit other conditions with similar cortical organization issues, suggesting it could be a promising new approach in neurorehabilitation for various disabilities.
Improved motor recovery after stroke and massive cortical reorganization following Constraint-Induced Movement therapy.Taub, E., Uswatte, G., Morris, DM.[2019]
Constraint-induced movement therapy (CI therapy) shows promise in helping stroke patients regain upper limb function, particularly for those with some movement recovery, but its success relies heavily on patient cooperation and intensive practice.
Evidence suggests that CI therapy can lead to significant changes in the brain's motor cortex, indicating that the therapy not only aids in physical recovery but also promotes cortical reorganization, which is crucial for improving motor function.
Repetitive task practice: a critical review of constraint-induced movement therapy in stroke.Wolf, SL., Blanton, S., Baer, H., et al.[2019]

Citations

Constraint-Induced Movement Therapy after Stroke - PMCConstraint-induced movement therapy (CIMT) was developed to overcome upper limb impairments after stroke and is the most investigated intervention for treating ...
Effectiveness of modified constraint-induced movement ...The outcome of this evaluation support that mCIMT significantly improves the upper limb function of stroke patients. Moreover, group mCIMT modality and TR ( ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40313194/
Effectiveness of modified constraint-induced movement ...Conclusion: Modified constraint-induced movement therapy improves upper limb function in the acute and sub-acute stages of stroke recovery ...
Constraint-induced movement therapy after strokeConstraint-induced movement therapy (CIMT) was developed to overcome upper limb impairments after stroke and is the most investigated intervention for the ...
Effect of Constraint-Induced Movement Therapy on Upper ...We hypothesized that patients who received CIMT up to 9 months following stroke would improve upper extremity function compared with patients ...
The effect and safety of constraint-induced movement ...Our results showed that CIMT combined with conventional rehabilitation (CR) was superior to CR in improving MAL-AOU and MAL-QOM scores.
CONSTRAINT-INDUCED MOVEMENT THERAPY (CIMT) ...This study aimed to compare the effects of Constraint-Induced Movement Therapy (CIMT) and Mirror Therapy (MT) on hand function and spasticity in individuals ...
Modified constraint-induced movement therapy for lower ...Studies show that mCIMT improves motor function, functional mobility, balance, lower limb strength, weight-bearing, and walking ability with minor side effects.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security